NYU Long Island Mineola — Mineola, New York

NYU Long Island Mineola is a clinical research site located in Mineola, New York, United States 11501.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

NYU Long Island Mineola has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma.

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU Long Island Mineola?

NYU Long Island Mineola has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU Long Island Mineola conducted?

NYU Long Island Mineola has 1 clinical trials on record, with 1 currently active. Their work covers Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma.

Is NYU Long Island Mineola accredited by Crixeo Health?

NYU Long Island Mineola has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NYU Long Island Mineola?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.